Statera Biopharma Inc. Soared

Mon, Oct 17, 2022 at 09:10 PM
Statera Biopharma Inc. Soared

Statera Biopharma Inc. (STAB:NASDAQ) soared at $0.21, representing a gain of 35.2%. On Mon, Oct 17, 2022, STAB:NASDAQ hit a New 2-Week Intraday High of $0.23. The stock appeared on our News Catalysts scanner on Mon, Oct 17, 2022 at 04:14 PM in the 'BIOTECH' category. From Tue, Oct 04, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days

The stock spiked on Thu, Oct 06, 2022 at $0.3 with a volume of 84M+.

About Statera Biopharma Inc. (STAB:NASDAQ)

Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.